Dyslipidaemia, hypercoagulability and the metabolic syndrome
about
The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balanceDo we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?The current role of thiazolidinediones in diabetes management.Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatmentClopidogrel resistance response in patients with coronary artery disease and metabolic syndrome: the role of hyperglycemia and obesity.Elevated body mass index and risk of postoperative CSF leak following transsphenoidal surgeryMaternal high-fat diet impacts endothelial function in nonhuman primate offspring.Metabolic syndrome in rheumatoid arthritisClinical importance and therapeutic modulation of small dense low-density lipoprotein particles.The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?Characteristics of urban sidewalks/streets and objectively measured physical activityApolipoprotein polymorphism is associated with pro-thrombotic profile in non-demented dyslipidemic subjects.Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study.Pleiotropic effects of thiazolidinediones.Endothelial cells microparticle-associated protein disulfide isomerase promotes platelet activation in metabolic syndrome.Oxidative stress as a common mediator for apoptosis induced-cardiac damage in diabetic rats.Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients.Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome.
P2860
Q27003277-EF0923B3-A222-487C-BF43-BC92FB09ABB2Q28222549-8CFEC8F1-3AEC-4B80-A848-1360BE010F6FQ30250347-16D3CFD6-D994-4E3F-9A0E-A5829802509EQ34002877-DF4D41FB-8483-4DC9-A5D3-296F2131B559Q35029623-B4544B3A-B55D-494E-9366-7C4F9056B891Q36011287-61BC23C7-DBC4-4119-893C-C8D8076977E6Q36254191-3865E144-A5BF-400D-8E08-438AC18DF326Q36309898-11491E1F-D64B-4F30-A708-E2D7F57FA433Q36568868-9894FF75-99D6-4AFE-99C3-79B18CCC49C6Q36675450-2AA9258B-8A05-4CA8-8004-C313AD484337Q36709546-4FBF21A2-47AD-41B7-98FE-C1CD9BEFAEEDQ36725049-5C5239DB-38CC-4B57-8D9D-F952133EE77AQ37070957-E1F88454-F886-4D96-9440-EF909C89CF31Q37129611-B80A02D0-E75F-45A8-BE20-9C2DE3DDD79FQ37142044-6B782053-9847-4A33-883E-7D8C4CA0D5EFQ37696296-92FF4E49-16A2-4903-984B-DDAC5C242E24Q41912037-77BFC7D2-9442-4528-8DCC-6DDA19094E8FQ46372426-E6454CA0-4DA2-4393-95C2-4F4ECABC0CF2Q53403417-956D7485-D23A-4961-99C3-3CEA17EBEC39
P2860
Dyslipidaemia, hypercoagulability and the metabolic syndrome
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Dyslipidaemia, hypercoagulability and the metabolic syndrome
@ast
Dyslipidaemia, hypercoagulability and the metabolic syndrome
@en
Dyslipidaemia, hypercoagulability and the metabolic syndrome
@nl
type
label
Dyslipidaemia, hypercoagulability and the metabolic syndrome
@ast
Dyslipidaemia, hypercoagulability and the metabolic syndrome
@en
Dyslipidaemia, hypercoagulability and the metabolic syndrome
@nl
prefLabel
Dyslipidaemia, hypercoagulability and the metabolic syndrome
@ast
Dyslipidaemia, hypercoagulability and the metabolic syndrome
@en
Dyslipidaemia, hypercoagulability and the metabolic syndrome
@nl
P2093
P1476
Dyslipidaemia, hypercoagulability and the metabolic syndrome
@en
P2093
Anna I Kakafika
Asterios Karagiannis
Dimitri P Mikhailidis
P304
P356
10.2174/157016106777698432
P407
P577
2006-07-01T00:00:00Z